December 16, 2009
Social Media Analysis Uncovers Preferred Medications, Most Discussed Therapies, Physician Concerns about Lifestyle Coaching, and Affordability Issues
Cambridge, MA — SERMO, the world’s largest online community for physicians, today announced the results of a new SERMO Vitals Report titled “Diabetes: MD Social Media Conversations.” The report examines physician dialog about diabetes over a one-year period and provides a complete analyses of a variety of topics, including the therapies physicians discuss most frequently, the brands they prefer, and candid/verbatim comments on issues related to diabetes.
Leveraging SERMO’s social media platform, the report examines more than 4,600 comments generated by 1,531 physicians from 11/08-10/09 and measures changes in physician sentiment and perceptions over this time period.
Diabetes is the 3rd most discussed disease state within the SERMO community. Through this report, organizations now have a looking glass into the organic, peer-to-peer discussions physicians have about diabetes every day.
Top companies and medications discussed and analyzed in this report include Byetta (Amylin and Lilly), Metformin, Liraglutide (Novo Nordisk), VIAject (Biodel), Avandia (GlaxoSmithKline), Januvia (Merck), Onglyza (AstraZeneca Bristol-Myers Squibb), Lantus (sanofi-aventis), Humalog (Lilly), and Actos (Takeda).
Visit http://www.SERMO.com/diabetes or call 877-778-3963 to view the full report.
SERMO Vital Reports mine organic physicians conversations about drugs, therapeutic areas, disease states and more. This is only possible through SERMO’s social media platform, which allows physicians nationwide to collaborate and exchange observations about drugs, devices and clinical issues – entirely online. Through a unique set of social media tools, SERMO taps into this dialog to quantify the impact of conversations as they unfold.
Each SERMO Vitals Report includes both quantitative and qualitative insight from real-world physician conversations. Reports are in PowerPoint format and include full discussion analysis. All physicians on SERMO are verified and credentialed, ensuring they have valid, active licenses to practice medicine in the United States. Visit www.SERMO.com/diabetes to learn more.
SERMO is the largest online physician community in the US. It’s where over 110,000 practicing physicians collaborate on difficult cases and exchange observations about drugs, devices and clinical issues. Through a unique set of social media tools, SERMO provides access to its community for organizations that need fast, actionable MD insights into treatments, drugs and devices. Visit http://www.SERMO.com to learn more.